4//SEC Filing
Berkenblit Anna 4
Accession 0001415889-23-002106
CIK 0000855654other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 5:22 PM ET
Size
10.5 KB
Accession
0001415889-23-002106
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
Berkenblit Anna
VP & Chief Medical Officer
Transactions
- Award
Restricted Stock Unit
2023-02-03+42,700→ 42,700 totalExercise: $0.00→ Common Stock (42,700 underlying) - Award
Stock Option (right to buy)
2023-02-03+256,300→ 256,300 totalExercise: $4.66Exp: 2033-02-03→ Common Stock (256,300 underlying) - Award
Restricted Stock Unit
2023-02-03+63,400→ 63,400 totalExercise: $0.00→ Common Stock (63,400 underlying)
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
- [F2]The RSUs vest over a three-year period, with 33 1/3% of the RSUs vesting on each of the first three anniversaries of the date of grant, subject to continued service through each vesting date.
- [F3]These options vest over a four-year period, with 25% of the shares vesting on the one-year anniversary of the date of grant, and thereafter an additional 6.25% of the shares vesting on each succeeding quarterly anniversary of the date of grant.
- [F4]The RSUs shall vest with respect to 40% of such RSUs on the one-year anniversary of the date of grant and with respect to the remaining 60% of such RSUs on the eighteen-month anniversary of the date of grant, subject to continued service through each vesting date.
Documents
Issuer
ImmunoGen, Inc.
CIK 0000855654
Entity typeother
Related Parties
1- filerCIK 0001691868
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 5:22 PM ET
- Size
- 10.5 KB